Ledger.Open graph →
SEC Form D · filed April 15, 2022

UBIVAC, INC

Offering
$5.0M
Sold
$250K
Exemption
Rule 506(c)
Industry
Biotechnology
Location
PORTLAND, OR
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (16)

Hong-Ming A. Hu, Ph.D · Portland, ORExec · DirectorBernard A. Fox, Ph.D · Portland, ORExec · DirectorBernard A. Fox, Mba · Portland, ORExecSteve A. Buhaly · Portland, ORExecNancy A. Lime · Portland, ORExecRichard Yeatman · Maidenhead, United KingdomExec · DirectorKen Davenport · New York, NYExecAdam R. Shaw · New York, NYExecRyan Morely · Maidenhead, United KingdomExec · DirectorJon A. Wigginton, M.D · Portland, ORDirectorFred F. Wang · New York, NYExecJason A. Hirsch · New York, NYExecAlan Borrelli · Manhasset, NYExec · DirectorPaul E. Singer · West Palm Beach, FLExec · DirectorJon A. Wigginton, M.D · Portland, ORDirectorNancy A. Lime · Portland, ORExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗